Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies targeting TNF superfamily receptors with applications in oncology, inflammation, autoimmunity, and infectious disease
Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies targeting TNF superfamily receptors with applications in oncology, inflammation, autoimmunity, and infectious disease.